Integrated Diagnostics Expands Stake in Saudi Biolab

Integrated Diagnostics Holdings (GB:IDHC) has released an update.

Pick the best stocks and maximize your portfolio:

Integrated Diagnostics Holdings has increased its stake in Biolab KSA to 79% after acquiring an additional 49% from Izhoor Holding Medical Company for USD 3.2 million. This strategic move aims to accelerate the company’s expansion in the Saudi Arabian market, which offers significant growth potential due to its large and underserved population. The acquisition is expected to strengthen IDH’s presence and enhance its service delivery in the region.

For further insights into GB:IDHC stock, check out TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.